Is Cynosure, Inc. (CYNO) A Good Stock To Buy Right Now?
Is Cynosure, Inc. (NASDAQ:CYNO) a good stock to buy here? Prominent investors are definitely becoming less confident. The number of long hedge fund positions were trimmed by 1 lately.
Cynosure Inc (CYNO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Falcon Point Capital James Bitzer | 0 | $0 | 0% | |
| 2. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 0 | $0 | 0% | |
| 3. | Paloma Partners Donald Sussman | 0 | $0 | 0% | |
| 4. | Tudor Investment Corp Paul Tudor Jones | 0 | $0 | 0% | |
| 5. | Perceptive Advisors Joseph Edelman | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.60 | 3,000 | Director | 3,000 | 2013-11-05 | Filing | |
| $8.00 | 2,500 | Officer | 2,500 | 2008-11-12 | Filing | |
| $8.50 | 1,477 | Officer, Director | 2,500 | 2008-11-12 | Filing | |
| $8.00 | 1,023 | Officer, Director | 1,023 | 2008-11-12 | Filing | |
| $5.90 | 2,500 | Officer, Director | 5,000 | 2009-02-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $45.00 | 2,042 | Officer | 0 | 2016-11-22 | Filing | |
| $45.00 | 5,833 | Officer | 0 | 2016-11-21 | Filing | |
| $45.00 | 10,055 | Officer, Director | 0 | 2016-11-22 | Filing | |
| $45.00 | 2,007 | Officer, Director | 0 | 2016-11-21 | Filing | |
| $45.00 | 4,222 | Officer, Director | 0 | 2016-11-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% |
News See All
Fat Wars: Is Jim Chanos Short ZELTIQ Aesthetics Inc (ZLTQ)?
Since institutional investors have released their equity portfolios for the end of the second quarter, Insider Monkey has analyzed the latest 13F filings of some 750 investors in order to determine ...
Cynosure Inc (CYNO): Billionaire Steve Cohen's Point72 Asset Management Reports New Investment
As a recent 13G filing with the US Securities and Exchange Commission showed, billionaire Steve Cohen's Point72 Asset Management has initiated a stake in Cynosure, Inc. (NASDAQ:CYNO).
Pay Attention to These 5 Stocks Making Big Moves Today
The Dow Jones is slightly in the red today as market sentiment dips on a more mixed batch of earnings results being released today. Origin Agritech Ltd.
Hedge Funds Are Crazy About Cynosure, Inc. (CYNO)
At Insider Monkey, we pore over the filings of more than 700 top investment firms every quarter, a process we have now completed for the latest reporting period.
iRobot Corporation (IRBT), Xcerra Corp (XCRA), Applied Micro Circuits Corporation (AMCC): SG Capital Management’s Top Q2 Picks
SG Capital Management, a fund led by Ken Grossman and Glen Schneider, filed today its Form 13F for the second quarter of 2014.
Hedge Funds Aren't Crazy About Given Imaging Ltd. (GIVN) Anymore
At the moment, there are plenty of methods shareholders can use to track stocks. Two of the most underrated are hedge fund and insider trading movement.
Should You Sell Symmetry Medical Inc. (SMA)?
In today’s marketplace, there are many gauges shareholders can use to monitor the equity markets. A pair of the most innovative are hedge fund and insider trading movement.
Hedge Funds Are Betting On Cynosure, Inc. (CYNO)
In the eyes of many of your fellow readers, hedge funds are viewed as useless, outdated financial vehicles of a period lost to current times.
Here is What Hedge Funds Think About Invacare Corporation (IVC)
To many of your peers, hedge funds are perceived as useless, outdated investment vehicles of an era lost to time.